Hepatitis C and interferon: fewer cases of liver cancer
Prescrire International 22(140): 191
2013
ISSN/ISBN: 1167-7422 PMID: 23951600 Document Number: 668579
Data on the risk of hepatocellular carcinoma in interferon-treated patients with chronic hepatitis C participating in placebo-controlled trials of interferon have been published after 3 to 9 years of follow-up. Among patients with chronic hepatitis C and either fibrosis or cirrhosis, interferon greatly reduced the risk of hepatocellular carcinoma after 8 years or more, especially when viral load was below the limit of detection.
Document emailed within 1 workday
Related Documents
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042Van Thiel, D.H.; Wright, H.I.; Gavaler, J.S.; Fung, J.; Starzl, T.E. 1991: Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine Transplantation Proceedings 23(6): 3052-3053
Piqueras, B.; Salcedo, M.; Bañares, R.; García-Durán, F.; Baños, E.; de Diego, A.; Roldán, P.; Cos, E.; Clemente, G. 1997: Famciclovir plus interferon in the treatment of a patient with chronic hepatitis B and severe liver failure Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 89(3): 217-221
Kawada, E.; Shinonome, S.; Tamura, J.; Murakami, H. 1994: Decrease in serum ferritin level in a patient with HCV hepatitis and liver hemosiderosis by interferon-alpha Journal of Medicine 25(6): 388-392
Levitan, B.N.; Astakhin, A.V.; Chishieva, E.M.; Afanas'ev, S.S. 2004: Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis Voenno-Meditsinskii Zhurnal 325(2): 60
Tang, Y.H. 1983: The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining Zhonghua Nei Ke Za Zhi 22(1): 17-20; 62-63
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C. 1995: Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
Morokoshi, Y.; Morimoto, T.; Yamamoto, M.; Ono, M.; Kawai, K.; Yakushiji, M.; Sugahara, T.; Takata, C.; Kimoto, T. 1988: A case of cystadenocarcinoma of the liver complicated by gastric cancer--a review of 83 cases of primary cystic liver cancer in the literature Gan no Rinsho. Japan Journal of Cancer Clinics 34(9): 1174-1184
Müller, C.; Zielinski, C.C. 1987: Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis Acta Medica Austriaca 14(5): 115-118
Rao, H-ying.; Wei, L.; Li, J.; Zhang, L-fang.; Chen, H-yong.; Zhu, L-min.; Liu, F.; Sun, Y.; Wang, H. 2009: Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response Hepato-Gastroenterology 56(90): 328-334
Mukherjee, S.; Lyden, E. 2006: Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series Hepato-Gastroenterology 53(70): 561-565
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Srivastava, S.; Bertagnolli, M.; Lewis, J.H. 2005: Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic Journal of the National Medical Association 97(12): 1703-1707
Dahlqvist, G.; Horsmans, Y.; Komuta, M.; Coubeau, L. 2019: Acute liver graft cellular rejection after interferon-free antiviral treatment for HCV infection. Is there a risk? a warning about three cases Acta Gastro-Enterologica Belgica 82(1): 53-56
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Grasés, P.J.; Pastrán, Z.; Cáceres, A.M.; Perdomo, M.M.; Ceballos, M. 1983: Granulomatous hepatitis. Clinicopathological spectrum in 107 cases with liver biopsy G.E.N 37(3): 199-232
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211